Commonwealth Equity Services’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
MCO
LG
CFM
Commonwealth Equity Services's CLPT Position: Q2 2026 in Review
Commonwealth Equity Services reduced its ClearPoint Neuro (CLPT) stake by 4.8% in Q2 2026, selling an estimated $42.5K and leaving 68,048 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2558.
Commonwealth Equity Services first reported a position in CLPT in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.4M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.
- Commonwealth Equity Services held 68,048 shares of ClearPoint Neuro worth $1.21M as of Q2 2026.
- Commonwealth Equity Services sold 3,400 ClearPoint Neuro shares in Q2 2026, an estimated $42.5K.
- ClearPoint Neuro made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2558 holding.
- Commonwealth Equity Services first reported a position in ClearPoint Neuro in Q3 2021 and has held it in 20 quarters since.
- Commonwealth Equity Services's ClearPoint Neuro position peaked at $1.4M in Q3 2025.
- 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.